Rasagiline orally disintegrating compositions

Details for Australian Patent Application No. 2005309817 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Licht, Daniella; Gilbert, Adrian; Patashnik, Shulamit

Agent FB Rice

Pub. Number AU-B-2005309817

PCT Pub. Number WO2006/057912

Priority 10/997,785 24.11.04 US; 60/630,918 24.11.04 US

Filing date 17 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 18 August 2011

International Classifications

A61K 31/4166 (2006.01)

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057912 Priority application(s): WO2006/057912

18 August 2011 Application Accepted

  Published as AU-B-2005309817

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309818-2-methylene-19-nor-(20R)-1-alpha-hydr oxy-bishomopregnacalciferol

2005309808-Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide